SynAct Pharma AB announced at its extraordinary general meeting held on March 20, 2024, Anders Kronborg, Sten Scheibye, Sten Sørensen, and Jeppe Øvlesen was elected new members of the board. Anders Kronborg was elected chairman of the board of directors.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.84 SEK | -0.94% | -8.68% | -22.54% |
Mar. 20 | Sweden's SynAct Pharma Names New CEO | MT |
Mar. 20 | SynAct Pharma AB Elects New Board Members and Chairman at Extraordinary General Meeting | CI |
1st Jan change | Capi. | |
---|---|---|
-22.54% | 22.15M | |
-0.33% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.09% | 24.63B | |
-24.53% | 18.2B | |
+26.47% | 12.01B | |
-3.57% | 11.76B | |
+11.31% | 10.4B | |
-1.59% | 9.94B |
- Stock Market
- Equities
- SYNACT Stock
- News SynAct Pharma AB
- SynAct Pharma AB Elects New Board Members and Chairman at Extraordinary General Meeting